Objectives: Describe the mechanism of action of RAI in the treatment of thyroid
malignancies. Outline RAI treatment indications and contraindications in thyroid cancers …

Radioactive iodine (RAI) has revolutionized the treatment of differentiated thyroid cancer
(DTC) since its development in the 1940s. 1 Quantifying the impact that RAI has had on the …

Radioactive iodine (RAI) in the form of 131 I has been used to treat thyroid cancer since
1946. RAI is used after thyroidectomy to ablate the residual normal thyroid remnant, as …

Radioiodine treatment for thyroid disease has been given for half a decade in Sweden. The
most common indication for treatment is hyperthyroidism, when iodine uptake is high. The …

The treatment of differentiated thyroid cancer continues to move away from a 'one size fits
all'approach to a process of tailored therapeutic decision-making that incorporates disease …

The Society of Nuclear Medicine and Molecular Imaging appreciates the opportunity to
comment on the article by Molenaar et al 1 that explores the risks of developing secondary …

Radioactive iodine (RAI) is used in treatment of patients with differentiated papillary and
follicular thyroid cancer. It is typically used after thyroidectomy, both as a means of imaging …

Thefirst reports of radionuclide therapy for thyroid disease used 130I, but 131I rapidly
became the favoured radionuclide with beta-and gamma-ray emissions and a half-life …

Prior planning for the administration of radioiodine therapy is important. Lowering iodine
levels, sufficiently stimulating the thyroid, checking baseline laboratory levels, ordering …

OBJECTIVE. The paradigm of theranostics is based on tailoring therapy for the purpose of
optimizing outcomes. This principle is being applied to radioactive iodine therapy …